湘南ヘルスイノベーションパーク (湘南アイパーク) は、2018年4月、武田薬品工業株式会社が湘南研究所を開放することにより設立された、企業発のサイエンスパークです。製薬企業のみならず、次世代医療、AI、ベンチャーキャピタル、行政など、幅広い業種や規模の産官学が結集し、エコシステムを形成することで、ヘルスイノベーションを加速する場となることを目指しています。
General Manager of Shonan iPark
Toshio Fujimoto is the General Manager of Shonan Health Innovation Park (iPark) since April 2018. In his current role, Dr. Fujimoto provides strategic leadership and oversight for all key iPark activities. He implements the iPark’s vision to be an open innovation ecosystem which builds meaningful collaborations with academia, biotech, pharma companies, and the government.
Dr. Fujimoto received his MD from Kyoto University and his MBA from Kobe University. He began his clinical practice as a Resident at the Department of Thoracic Surgery at Kyoto University Hospital. After completing several rotations at local area hospitals, he took a position in Germany as an Assistant Surgeon with the Thoracic Surgery Department at Ruhrlandklink Hospital, and later moved to the U.S. to serve as Clinical Fellow, General Thoracic Surgery at the Mayo Clinic.
Prior to joining Shonan iPark, Dr. Fujimoto held positions with increasing responsibility at Eli Lilly Japan. Most recently he was Vice President of the Medicine Development Unit, where he oversaw the R&D Management function in Japan.